[Studies on anti-inflammatory agents. II. Analgesic and anti-edematous activities of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6, 7-tetrahydrothieno (2,3-c)pyridine (Y-3642)].
D000632:Aminopyrine / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D004487:Edema / Q000139:chemically induced; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D010146:Pain; D010208:Papaverine / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D012459:Salicylates / Q000494:pharmacology; D013876:Thiophenes / Q000494:pharmacology*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D011725:Pyridines; D012459:Salicylates; D013876:Thiophenes; D000632:Aminopyrine; D009020:Morphine; D000661:Amphetamine; D010208:Papaverine; D010653:Phenylbutazone; D007099:Imipramine